drugset / Trial / NCT01658020
A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg
Phase 3
Completed
345 enrolled
Dong Wha Pharmaceutical Co. Ltd.
Ajou University · collabAsan Medical Center · collabBundang CHA Hospital · collabCatholic University of Korea Saint Paul's Hospital · collabChonbuk National University Hospital · collabChonnam National University Hospital · collabChosun University Hospital · collabChungbuk National University · collabChungnam National University Hospital · collabDongGuk University · collabEwha Womans University Mokdong Hospital · collabGachon University Gil Medical Center · collabGyeongsang National University Hospital · collabHallym University Medical Center · collabHanyang University · collabIncheon St.Mary's Hospital · collabInje University · collabKangWon National University Hospital · collabKangdong Sacred Heart Hospital · collabKeimyung University Dongsan Medical Center · collabKonkuk University Medical Center · collabKonyang University Hospital · collabKorea University Anam Hospital · collabKyunghee University Medical Center · collabMasan Samsung Hospital, South Korea · collabSeverance Hospital · collabThe Catholic University of Korea · collabUlsan University Hospital · collabWonju Severance Christian Hospital · collabYeungnam University Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to Evaluate the Efficacy and Safety Profiles of oral multiple dose of Zabofloxacin Tablet 400 mg.
Timeline
- Start
- 2012-08
- Primary completion
- 2014-01
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | Zabofloxacin | Small molecule | 367 mg | Oral |